Top tips and takeaways from www.healthnetworkcommunications.com/pharmapricing
............................................................................................................................................................................................................................................... We have put together the top 10 slides from our Pharma Pricing & Market Access Outlook Europe 2014 presentations. All of these slides were part of in-depth, informative presentations given by industry professionals, addressing the critical policy issues in developing the optimum pricing strategy for pharmaceutical products. We have chosen these slides and presentations to give you an idea of what to expect at our upcoming World Pharma Pricing & Market Access Congress 2015 event. For more information about this event, click here We hope that you find this content beneficial and informative. As always if you have any comments leave them in our LinkedIn group or tweet them to us @totalbiopharma #pharmapricing2015 Bernadette Stansfield General Manager World Pharma Pricing & Market Access Congress 2015 +44 (0)20 7608 7057 bstansfield@healthnetworkcommunications.com ...............................................................................................................................................................................................................................................
www.healthnetworkcommunications.com/lpdebook ............................................................................................................................................................................................................................................... 1. Part of the presentation on “Value based assessment: NICE’s role” by David Haslam, Chairman, NICE Download the full presentation ...............................................................................................................................................................................................................................................
www.healthnetworkcommunications.com/lpdebook ............................................................................................................................................................................................................................................... 2. Part of the presentation on “Update on the New HTA in France” By Jean-Luc Harousseau, President, HAS, France Download the full presentation ...............................................................................................................................................................................................................................................
www.healthnetworkcommunications.com/lpdebook ............................................................................................................................................................................................................................................... 3. Part of the presentation on “Latest Results of early benefit assessments and price negotiations” by Meriem Bouslouk, PhD, Pharmaceuticals Department, Federal Joint Committee, Germany Download the full presentation ...............................................................................................................................................................................................................................................
www.healthnetworkcommunications.com/lpdebook ............................................................................................................................................................................................................................................... 4. Part of the presentation on “ The Netherlands: How to anticipate future pharma and healthcare dynamics?” by Cornelis Boersma, Head of New Products & Market Entry, GlaxoSmithKline Download the full presentation ...............................................................................................................................................................................................................................................
www.healthnetworkcommunications.com/lpdebook ............................................................................................................................................................................................................................................... 5. Part of the presentation on “Italy : update on the reform agenda” by Giovanni Tafuri, Office for Pharmaceutical Policy, AIFA, Italy Download the full presentation ...............................................................................................................................................................................................................................................
www.healthnetworkcommunications.com/lpdebook ............................................................................................................................................................................................................................................... 6. Part of the presentation on “ The Netherlands: In the mi(d)st of change” By Martin Van der Graaf, Secretary, Medicinal Product Reimbursement Committee, CVZ Download the full presentation ...............................................................................................................................................................................................................................................
........................................................................................................................................................................................................................................ www.healthnetworkcommunications.com/lpdebook Your still not done with Pharma Pricing & Market Access? The 9th annual World Pharma Pricing & Market Access Congress is the world’s largest gathering of pharmaceutical pricing, market access and reimbursement professionals regularly attracting a high attendance. This three day strategic conference will address the critical policy issues in developing the optimum pricing strategy for pharmaceutical products. Download the brochure for more details Join the conversation Click here to leave a comment about this eBook on the Total Biopharma blog Click here to contribute to our LinkedIn discussion Click here to follow us on Twitter @totalbiopharma Click here to sign up for the Total Biopharma e-newsletter ...............................................................................................................................................................................................................................................
Recommend
More recommend